Skip to content
Search

Latest Stories

CCA report highlights success: 90,000 pharmacy first consultations in first two months

CCA report highlights success: 90,000 pharmacy first consultations in first two months
The pharmacy first report reveals impressive uptake and patient satisfaction in just two months

In a recent report released by the Company Chemists’ Association (CCA), data from the NHS Pharmacy First service indicates a substantial uptake and positive impact on patient care just two months after its launch.

The CCA's findings shed light on the service's efficacy in meeting patient needs and its potential to alleviate pressure on General Practices (GPs) within the NHS.


According to the report, over 90,000 Pharmacy First consultations were conducted solely by CCA members within the initial two-month period.

Impressively, 88 per cent of these consultations, totaling 81,627, were deemed eligible for NHS-funded care indicating a significant demand for the service among patients.

In the first month, the data revealed that more than 90 per cent of eligible patients received necessary care directly through Pharmacy First, bypassing the need for further referral.

Furthermore, in 75 per cent of cases, pharmacists were able to supply medication, highlighting the pivotal role community pharmacies play in managing common conditions.

One notable aspect of the data was the responsible use of antibiotics.

Pharmacists demonstrated judicious stewardship by supplying antibiotics only when absolutely necessary, dispelling prior concerns about the service contributing to antibiotic resistance.

The report also underscores the convenience and accessibility of Pharmacy First, with nearly three-quarters of consultations initiated by patients themselves.

Despite this, the report emphasised on the importance of optimizing referral pathways from GP surgeries and NHS111 to ensure all patients have access to the service when needed.

Looking ahead, the CCA advocates for targeted support for General Practices to facilitate more referrals to Pharmacy First, thereby reducing the burden on GPs.

Additionally, they propose investing in robust public engagement campaigns to raise awareness about the service's availability.

Malcolm Harrison, Chief Executive of the CCA, lauded the success of Pharmacy First in providing timely access to NHS care stating, "the Pharmacy First service continues to show immense promise."

He stressed the necessity of continued funding beyond March 2025, along with measures to address historical underfunding in the pharmacy sector.

The Pharmacy First service, launched in January 2024, allows pharmacists to provide advice and prescription-only medicines for seven common conditions.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less